he good news is that there is clinical
proof you can build a powerful antioxidant
defense system against prostate
cancer. By incorporating LYC-O-MATO® (standardized
natural tomato extract) into your
daily nutrition program you can access
remarkable fighting power against prostate
cancer and a host of other degenerative
diseases.
 The standardized natural tomato extract
contains several phytonutrients found in
tomatoes including lycopene, tocopherols,
vitamin E, phytofluene, phytoene, phytosterols,
beta carotene and more. LYC-O-MATO is
extracted from non-GMO tomatoes grown in
Israel that contain four times the lycopene
content of tomatoes grown elsewhere.
A six-year Harvard Medical School study
of healthy males found that consuming
tomatoes, tomato sauce or pizza more than
twice a week, as opposed to never, was associated
with a reduced risk of prostate cancer of
21 to 34 percent, depending on the food.
As exciting as its cancer-prevention potential
is the evidence that shows lycopene may
help fight existing cancer. A recent paper published
in the Cancer Epidemiology, Biomarkers
and Prevention by Omer Kucuk, M.D., professor
of medicine and oncology, and his colleagues
at the Karmanos Cancer Institute in
Detroit, Michigan, evaluated the effect
encapsulated LYC-O-MATO had on
patients with existing
prostate cancer. In this study,
Dr. Kucuk and colleagues
followed 30 men with
localized prostate
cancer who were
scheduled to
undergo surgical
removal of
the prostate. For
three weeks prior to
surgery the study participants were randomly
assigned to receive either 250 milligrams
LYC-O-MATO from LycoRed Natural Products,
Beer-Sheva, Israel (which contains 15 milligram
of lycopene) twice daily or no intervention.
Following removal of the prostates,
the glands were analyzed to determine
whether there were any differences between
the two study groups.
The investigators found that the treated
group had smaller tumors, which were more
likely to be confined to the prostate. Levels of
serum PSAwere found to decline in the patients
who received LYC-O-MATO tomato extract. In
addition, the tumors in patients who consumed
this natural lycopene showed signs of
regression and decreased malignancy.
“This was the first published report from a
randomized prospective clinical trial
showing the efficacy of a tomato extract
supplement against prostate cancer,” said
Dr. Kucuk. “Previous reports were largely
epidemiological studies showing an association
between consumption of tomato products and
decreased risk of prostate cancer. Furthermore,
our findings suggest that a tomato extract in the
form of LYC-O-MATO may not only help prevent
prostate cancer but also may be useful in treating
prostate cancer.”
Research using standardized LYC-O-MATO
natural tomato extract is also good news for
mild hypertensive patients reluctant to make
lifestyle changes.
New findings published in the May issue
of The American Journal of Hypertension
provide evidence that LYC-O-MATO may
help lower blood pressure in
hypertensive patients. The
study, presented at the
Sixteenth Annual Scientific
Meeting of the American
Society of Hypertension on
May 18, 2001, may provide a new alternative for about 50 million
Americans who have hypertension.
Americans interested in lowering their risk
of high blood pressure are frequently encouraged
to exercise and follow a low-fat diet rich
in fruits and vegetables. Typically, however,
many are reluctant to make changes in their
lifestyles. In fact, according to NOAH, an
online health resource maintained by City
University of New York, only 68 percent are
aware of their high blood pressure condition
and only 27 percent have it under control.
High blood pressure contributes to 75 percent
of all strokes and heart attacks.
Now there is a natural alternative to controlling
hypertension that may prevent
Americans from making difficult lifestyle
changes and/or taking drugs with harmful
side effects.
In a single-blind, placebo-controlled
crossover trial, Esther Paran, M.D., the study’s
principal investigator, evaluated the effect of
LYC-O-MATO® on grade 1 hypertensive
patients. In this study, 30 grade 1 hypertensive
patients between the ages of 45–60 were
administered a daily dose of identical placebos
for the first four weeks of the study, followed
by a 250 mg daily dose of LYC-O-MATO® for the
final eight weeks of the study.
Preliminary results of this study indicate a
significant reduction in systolic blood pressure
in treated patients. “We are optimistic about
LYC-O-MATO’S potential in managing hypertension,”
Dr. Paran said. “The results of this
study demonstrate the ability of LYC-O-MATO®
to reduce systolic blood-pressure, warranting
additional studies in the future.”
Other recent studies suggest that LYC-OMATO
® also provides a considerable level of
defense against degenerative diseases including
heart disease. Considering the results of
these studies, combined with its positive
effects on blood pressure, the importance
of maintaining a normal level of natural
phytonutrients like lycopene, phytoene,
phytofluene and beta carotene in the human
body is evident. It is recommended that
individuals consume at least 80–250 mg of
LYC-O-MATO® per day, which contains 15 mg of
lycopene as well as other phytonutrients, to
maintain good health.
For more information visit www.lycomato.com, or the American Society of Hypertension at www.ash-us.org
|
